## MTD: Mettler-Toledo International, I - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.9% below STRENGTH zone (3.0-6.0%); PEG 5.76 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1338.59)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Barclays Has Lowered Expectations for Mettler-Toledo International (NYSE:MTD) Stock Price**
- Source: MarketBeat | 20251215T212634 | Neutral | Relevance: 100%
- Barclays has lowered its price target for Mettler-Toledo International (NYSE:MTD) from $1,600 to $1,550, while maintaining an "overweight" rating, suggesting a 9.57% upside. Despite this, analysts are split, with a consensus "Hold" rating and an average price target of $1,441.67. The company recently exceeded Q3 earnings expectations and provided strong FY2025 EPS guidance, although insiders have sold a significant amount of shares recently.

**2. Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,450.00 at Wells Fargo & Company**
- Source: MarketBeat | 20251215T190522 | Somewhat-Bullish | Relevance: 100%
- Wells Fargo & Company has increased its price target for Mettler-Toledo International (NYSE:MTD) to $1,450.00 from $1,400.00, maintaining an "equal weight" rating. This new target suggests a potential upside of 3.09% from the stock's current price. Other analysts have varying targets, contributing to a MarketBeat consensus "Hold" rating with an average target of $1,445.83.

**3. Corient Private Wealth LLC Acquires 67,149 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251215T100839 | Somewhat-Bullish | Relevance: 100%
- Corient Private Wealth LLC significantly increased its stake in Mettler-Toledo International (NYSE:MTD) by 91.8% in the second quarter, adding 67,149 shares to its portfolio. Other institutional investors also adjusted their positions, and company insiders sold shares totaling over $3 million. Analysts have mixed ratings on the stock, with an average price target of $1,424.17, while the company reported strong Q3 earnings, surpassing revenue and EPS estimates.

**4. 22,039 Shares in Mettler-Toledo International, Inc. $MTD Purchased by Hudson Bay Capital Management LP**
- Source: MarketBeat | 20251214T130829 | Somewhat-Bullish | Relevance: 100%
- Hudson Bay Capital Management LP has acquired a new stake of 22,039 shares in Mettler-Toledo International, Inc. (NYSE:MTD) during the second quarter, valued at approximately $25.89 million, representing 0.11% ownership. Despite this institutional buying, company insiders have sold over 19,565 shares worth about $28.68 million in the last three months. Analysts currently maintain a "Hold" rating for Mettler-Toledo, with a consensus target price of $1,424.17.

**5. Stance Capital LLC Buys Shares of 1,713 Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251214T125138 | Neutral | Relevance: 100%
- Stance Capital LLC has acquired a new position of 1,713 shares in Mettler-Toledo International, Inc. (NYSE:MTD) during the second quarter, valued at approximately $2,012,000. Several other institutional investors also modified their holdings in the medical instruments supplier, with institutional ownership now at 95.07%. The article also details recent insider stock sales and analyst ratings, which currently give Mettler-Toledo a consensus "Hold" rating with an average target price of $1,424.17.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Barclays | $1550 | $1600 | -3% |
| 2025-12-15 | Wells Fargo | $1450 | $1400 | +4% |
| 2025-12-09 | Goldman Sachs | $1475 | $0 | 0% |
| 2025-12-02 | Morgan Stanley | $1550 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Barclays | main | Overweight |
| 2025-12-15 | Wells Fargo | main | Equal-Weight |
| 2025-12-09 | Goldman Sachs | init | Neutral |
| 2025-12-02 | Morgan Stanley | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 18 ($1.28M) |
| Sells | 6 ($0.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+1.4%)
- Blackrock Inc.: 9.2% (-3.1%)
- State Street Corpora: 4.7% (-0.5%)
- Capital Internationa: 4.2% (+1.2%)
- Bank Of New York Mel: 4.0% (-9.0%)

### Key Risks

1. Valuation stretched: PEG 5.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +7.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 5.76 signals overvaluation risk, limited margin of safety. Forward P/E 30.9x stretched relative to 8% growth. Quality metrics strong (ROE 30%, ROA 20%, margin 21%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.1B |
| Beta | 1.40 |
| 52W Range | $946.69 - $1525.17 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.76 |
| Forward P/E | 30.9 |
| Current P/E | 33.5 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -5.6% to 1.9% (+7.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >3.0% for momentum thesis). MRS_5 at 2.4% confirms short-term momentum alignment. Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). MACD histogram bearish (-7.32), momentum weakening. RSI neutral at 49. OFD pattern: -DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.86% (CS: 47) | Neutral |
| RSI_14 | 49.4 | Neutral |
| MACD Histogram | -7.32 | Bearish |
| vs SMA20 | 0.989x | Below |
| vs SMA50 | 1.009x | Above |
| vs SMA200 | 1.134x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1412.47
- **Stop Loss:** $1338.59 (5.2% risk)
- **Target:** $1486.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 16
- **Position Value:** $22,599.52
- **Portfolio %:** 22.60%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $12.80)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.66 | $11.15 | +4.6% |
| 2025Q2 | $9.60 | $10.09 | +5.1% |
| 2025Q1 | $7.88 | $8.19 | +3.9% |
| 2024Q4 | $11.72 | $12.41 | +5.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*